Please assess the completion status of the following clinical trial:

Trial Title: Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Restriction on pulmonary function testing (TLC \<80%, FEV1/FVC ratio \> predicted or DLCO \< 80%)~2. Evidence of fibrosis on high resolution computed tomography of the chest.~3. Fibrosis on surgical lung biopsy if performed~4. Referral for pulmonary rehabilitation~Exclusion Criteria:~1. Participation in pulmonary rehabilitation in the past 24 months~2. Inability to complete 6 minute walk test or study questionnaires~3. Limitations other than dyspnea (e.g. arthritis) that affect ability to participate in pulmonary rehabilitation~4. Baseline 6 minute walk distance \> 400 meters~5. Planned change in medication treatment for lung disease during the course of pulmonary rehabilitation~6. Ejection fraction known to be \< 25%~7. Contraindications to pulmonary rehabilitation (clinically unstable, uncontrolled arrhythmia or hypertension, symptomatic or uncontrolled hypotension with systolic blood pressure of \< 95, active angina, unexplained syncope or worsening dizziness, limiting orthopedic or neurological disorders, psychiatric impairment that inhibits cooperation in the program)~8. FEV1/FVC \< 65%~9. Unable to provide informed consent

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).